SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 8th, 2014 • Evolutionary Genomics, Inc. • Blank checks • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of the 1st day of October, 2014, by and among Michael Friess (“Friess”), Sanford Schwartz (“Schwartz”), Nick Boosalis (“Boosalis”), Desfaire, Inc., a Minnesota corporation (“Desfaire”), The Boosalis Group, Inc., a Minnesota corporation (“The Boosalis Group”; each a “Seller” and collectively, the “Sellers”) and Evolutionary Genomics, Inc. (the “Buyer”).
JOINT FILING AGREEMENTJoint Filing Agreement • June 16th, 2014 • Evolutionary Genomics, Inc. • Blank checks
This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • October 8th, 2014 • Evolutionary Genomics, Inc. • Blank checks
This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.
SECURITIES PURCHASE OPTION AGREEMENTSecurities Purchase Option Agreement • June 16th, 2014 • Evolutionary Genomics, Inc. • Blank checks • New York
This SECURITIES PURCHASE OPTION AGREEMENT (the “Agreement”) is made and entered into as of the 6th day of June, 2014, by and among Nick Boosalis, a resident of the state of Minnesota (“Boosalis”), Desfaire, Inc., a Minnesota corporation (“Desfaire”), The Boosalis Group, Inc., a Minnesota corporation (“The Boosalis Group”, together with Boosalis and Desfaire, each a “Seller” and collectively, the “Sellers”) and Evolutionary Genomics Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 16th, 2014 • Evolutionary Genomics, Inc. • Blank checks • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of the 6th day of June, 2014, by and among Michael Friess (“Friess”), Sanford Schwartz (“Schwartz”, together with Friess, each a “Seller” and collectively, the “Sellers”) and Evolutionary Genomics, Inc. (the “Buyer”).
